Literature DB >> 20140680

In vitro interactions between aged garlic extract and drugs used for the treatment of cardiovascular and diabetic patients.

Katja Berginc1, Simon Žakelj, Albin Kristl.   

Abstract

BACKGROUND: Disease preventing effects gained by garlic consumption have been recognized since early period of history, making commercially available garlic supplements attractive to the general public. Possible pharmacokinetic interactions which could occur between applied drugs and aged garlic extract (AGE) are unknown. AIM: To test in vitro impact of some garlic phytochemicals on P-glycoprotein (Pgp), the most recognized efflux transporter, and the effect of AGE on passive membrane permeability, absorptive and secretory intestinal transporters.
METHODS: Rat small intestine and Caco-2 cell monolayers, mounted in side-by-side diffusion chambers were used.
RESULTS: Hydrophilic sulphur compounds increased Pgp mediated Rhodamine 123 (Rho123) efflux, whereas the lipophilic ones increased Pgp efflux through rat ileum but not through Caco-2 cell monolayers. Increased activities of secretory (Pgp, multidrug-resistance associated protein 2) and absorptive (monocarboxylate transporter 1, organic anion transporting polypeptide) transporters involved in drug absorption were observed in rat small intestine and Caco-2 cell monolayers in the presence of AGE. Transport of drugs mediated by breast cancer resistance protein and H(+)-oligopeptide transporter 1 was activated in rat intestine but inhibited through Caco-2 cells. Passive membrane permeability of tested compounds remained unaltered through rat small intestine, while significant changes were observed with Caco-2 cell monolayers.
CONCLUSIONS: Due to the observed in vitro pharmacokinetic interactions between AGE and investigated cardiovascular, antidiabetic and antiviral drugs, in vivo absorption changes are possible, but the magnitude of change depends on the most profound process involved (influx, efflux, passive diffusion) in compounds permeability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140680     DOI: 10.1007/s00394-010-0095-x

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  42 in total

1.  Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.

Authors:  Wakaba Yamashiro; Kazuya Maeda; Masakazu Hirouchi; Yasuhisa Adachi; Zhuohan Hu; Yuichi Sugiyama
Journal:  Drug Metab Dispos       Date:  2006-04-19       Impact factor: 3.922

Review 2.  Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption.

Authors:  Bente Steffansen; Carsten Uhd Nielsen; Birger Brodin; André Huss Eriksson; Rikke Andersen; Sven Frokjaer
Journal:  Eur J Pharm Sci       Date:  2004-01       Impact factor: 4.384

3.  Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulation.

Authors:  Toshiya Katsura; Ken-Ichi Inui
Journal:  Drug Metab Pharmacokinet       Date:  2003       Impact factor: 3.614

4.  Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells.

Authors:  Xianyi Sha; Guijun Yan; Yunjuan Wu; Junchan Li; Xiaoling Fang
Journal:  Eur J Pharm Sci       Date:  2005-04       Impact factor: 4.384

5.  A novel high-throughput pepT1 transporter assay differentiates between substrates and antagonists.

Authors:  Teresa N Faria; Julita K Timoszyk; Terry R Stouch; Balvinder S Vig; Christopher P Landowski; Gordon L Amidon; C David Weaver; Doris A Wall; Ronald L Smith
Journal:  Mol Pharm       Date:  2004-01-12       Impact factor: 4.939

6.  Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat.

Authors:  Maciej J Zamek-Gliszczynski; Keith A Hoffmaster; Joan E Humphreys; Xianbin Tian; Ken-Ichi Nezasa; Kim L R Brouwer
Journal:  J Pharmacol Exp Ther       Date:  2006-07-20       Impact factor: 4.030

Review 7.  Garlic and cardiovascular disease: a critical review.

Authors:  Khalid Rahman; Gordon M Lowe
Journal:  J Nutr       Date:  2006-03       Impact factor: 4.798

Review 8.  The effect of food components on the absorption of P-gp substrates: a review.

Authors:  Sven Deferme; Patrick Augustijns
Journal:  J Pharm Pharmacol       Date:  2003-02       Impact factor: 3.765

9.  Ciprofloxacin permeability and its active secretion through rat small intestine in vitro.

Authors:  Simon Zakelj; Katja Sturm; Albin Kristl
Journal:  Int J Pharm       Date:  2006-03-10       Impact factor: 5.875

10.  Aged garlic extract stimulates p-glycoprotein and multidrug resistance associated protein 2 mediated effluxes.

Authors:  Katja Berginc; Simon Zakelj; Darko Ursic; Albin Kristl
Journal:  Biol Pharm Bull       Date:  2009-04       Impact factor: 2.233

View more
  4 in total

Review 1.  Drug interactions with herbal medicines.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Clin Pharmacokinet       Date:  2012-02-01       Impact factor: 6.447

2.  Efflux and uptake transporters involved in the disposition of bazedoxifene.

Authors:  Tina Trdan Lušin; Aleš Mrhar; Bruno Stieger; Albin Kristl; Katja Berginc; Jurij Trontelj
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-29       Impact factor: 2.441

3.  Unique vascular protective properties of natural products: supplements or future main-line drugs with significant anti-atherosclerotic potential?

Authors:  Mark Slevin; Nessar Ahmed; Qiuyu Wang; Garry McDowell; Lina Badimon
Journal:  Vasc Cell       Date:  2012-04-30

Review 4.  Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds.

Authors:  Peyman Mikaili; Surush Maadirad; Milad Moloudizargari; Shahin Aghajanshakeri; Shadi Sarahroodi
Journal:  Iran J Basic Med Sci       Date:  2013-10       Impact factor: 2.699

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.